ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,070.55
1.20%
US Tech 100
17,100.00
2.07%
Dow Jones
38,503.69
0.69%
Brent Oil
87.535
-0.03%
Bitcoin
66,598.44
0.28%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Xeris Biopharma Holdings Inc (XERS) Quote

Xeris Biopharma Holdings Inc

Xeris Biopharma Holdings Inc (XERS)

NASDAQ
1.785
0.005
(0.28%)
Closed April 23 4:00PM
Delayed by 15 minutes
1.82
0.00
(0.00%)
After Hours: 4:17PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
1.785
Bid
1.74
Ask
1.86
Volume
1,345,307
1.775 Day's Range 1.90
1.46 52 Week Range 3.26
Market Cap
250.007M
Previous Close
1.78
Open
1.80
Last Trade
22
@
1.8
Last Trade Time
Financial Volume
$ 2,464,601
VWAP
1.832
Average Volume (3m)
1,949,577
Shares Outstanding
140,453,467
Dividend Yield
-
PE Ratio
-4.02
Earnings Per Share (EPS)
-0.44
Revenue
163.91M
Net Profit
-62.26M

About Xeris Biopharma Holdings Inc

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company markets Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalem... Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company markets Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago, Illinois. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.xerispharma.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Xeris Biopharma Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker XERS. The last closing price for Xeris Biopharma was $1.78. Over the last year, Xeris Biopharma shares have traded in a share price range of $ 1.46 to $ 3.26.

Xeris Biopharma currently has 140,453,467 shares outstanding. The market capitalization of Xeris Biopharma is $250.01 million. Xeris Biopharma has a price to earnings ratio (PE ratio) of -4.02.

XERS Latest News

More News

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a...

April 03 2024
Business Wire

Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a...

April 02 2024
Business Wire

Form S-8 - Securities to be offered to employees in employee benefit plans

March 06 2024
Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

March 06 2024
Edgar (US Regulatory)

Form 8-K - Current report

March 06 2024
Edgar (US Regulatory)

Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events

Achieved Total Revenue of over $44M in the fourth quarter – a 34% increase from same period prior year and generated approximately $164M for the full year 2023, a 49% increase versus prior year...

March 06 2024
Business Wire

Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital

Improves cost of capital Increases committed capital to a total facility size of $215M Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to...

March 06 2024
Business Wire

Xeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a...

February 28 2024
Business Wire

Xeris to Present at the Oppenheimer 34th Annual Healthcare Life Science Conference

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a...

February 05 2024
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

January 31 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.065-3.513513513511.851.91.6915545331.77158842CS
4-0.355-16.58878504672.142.27991.6914986971.96811977CS
12-0.845-32.12927756652.633.261.6919495772.50775833CS
260.0452.586206896551.743.261.4619122882.34799298CS
52-0.545-23.39055793992.333.261.4614926522.3741176CS
156-2.125-54.3478260873.914.980.970118373122.47393045CS
260-7.565-80.90909090919.3512.980.970116436173.2192617CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NIVFNewGenIvf Group Ltd
$ 2.23
(74.22%)
137.08M
MTCMMTec Inc
$ 2.24
(43.59%)
6.07M
OPRTOportun Financial Corporation
$ 3.16
(40.44%)
11.71M
SHIMShimmick Corporation
$ 3.05
(35.56%)
1.19M
HKITHitek Global Inc
$ 1.35
(32.35%)
411.78k
ABEOAbeona Therapeutics Inc
$ 3.39
(-53.94%)
5.51M
GWAVGreenwave Technology Solutions Inc
$ 0.0696
(-44.89%)
37.05M
LICNLichen China Limited
$ 0.56
(-42.19%)
6.61M
MLECMoolec Science SA
$ 1.71
(-30.77%)
3.16M
VAXXVaxxinity Inc
$ 0.1971
(-26.89%)
2.11M
CYNCYNGN Inc
$ 0.113
(-6.61%)
326.58M
PEGYPineapple Energy Inc
$ 0.0561
(22.49%)
185.74M
SQQQProShares UltraPro Short QQQ
$ 11.91
(-4.49%)
139.15M
NIVFNewGenIvf Group Ltd
$ 2.23
(74.22%)
137.08M
TSLATesla Inc
$ 144.68
(1.85%)
124.55M

XERS Discussion

View Posts
Monksdream Monksdream 4 weeks ago
XERS under $3
👍️0
StocksNcash StocksNcash 1 month ago
Still here👍
👍️0
Frankestin Frankestin 2 months ago
We are ready?🙏
👍️0
Nadendla Nadendla 2 months ago
ya..:)
👍️0
StocksNcash StocksNcash 2 months ago
Your welcome
👍️0
buccaneer1961 buccaneer1961 2 months ago
Thankyou!
👍️0
StocksNcash StocksNcash 2 months ago
Not really sure, but there has been positive news on this company. My app tip ranks has a forecast $51!! I’m holding lol good luck
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
XERS...3.29 BREAK OUT COMING UP
👍️0
buccaneer1961 buccaneer1961 2 months ago
Green lately..whats the catalysts?
👍️0
StocksNcash StocksNcash 2 months ago
Buy hold and don’t look back$$$$$
👍️0
Monksdream Monksdream 2 months ago
XERS new 52 week high
👍️0
Rkrocks Rkrocks 12 months ago
Let’s hope to break 3.00 soon
👍️0
price_and_volume price_and_volume 2 years ago
Izzy Englander likes $XERS...

https://finance.yahoo.com/news/billionaire-israel-englander-pulls-trigger-133848525.html
👍️0
mess124 mess124 2 years ago
Anybody know what this is G85CVR010 ? It-showed-in-my-TD-acct-after

Strongbridge vanished and XERS showed up.


Thank you
👍️0
Elgordo84 Elgordo84 2 years ago
Yes indeed
👍️0
alchemytrader alchemytrader 2 years ago
Nice catch in the low 2.00s.
👍️0
Elgordo84 Elgordo84 2 years ago
Goodluck to all the Longs!
👍️0
$Money Bags$ $Money Bags$ 2 years ago
Ramping up for sure.
👍️0
Elgordo84 Elgordo84 2 years ago
I like what I see here!

Looks like a Trend reversal

Great with patience!

Let’s go $XERS

#EG84
👍️0
ahimsa27 ahimsa27 3 years ago
PDUFA New Years ?
👍️0
$Money Bags$ $Money Bags$ 3 years ago
They stalled the run when they first announced the merger, then silently listed their failed FDA trial in that q. They have more stuff in the pipeline and once the merger is done, maybe they can ramp revenue.
👍️0
ezyE ezyE 3 years ago
Can we make it rain here?
👍️0
kzivann kzivann 3 years ago
Premarket action .. nice news.


XERS
👍️0
tknuncle tknuncle 3 years ago
Where is the bottom to XERS? I grabbed a a couple hundred a few days ago and it just keeps dropping more an more. Even after the good news today and yesterday. I was hoping maybe someone had an opinion they would like to share. Also does anyone know the real OS or Float? When I look at the OTC website I see it hasn't been updated since March 22nd.

https://www.otcmarkets.com/stock/SLS/security

Thanks for any feed back. Much appreciated
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Item 5.

Ownership of 5 Percent or Less of a Class. If this statement is being
filed to report the fact that as of the date hereof the reporting person
has ceased to be the beneficial owner of more than 5 percent of the
class of securities, check the following [ X ].
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Blackrock sold 2.1m shares into it since their last filing in May until today. If they are done suppressing it now, maybe it can finally head north to where it belongs.
👍️0
Modlich Modlich 3 years ago
Company on verge of bullish long run consolidated after bull flag bo last 2 days, imo anything over 5.2
and this could easily hit 7.8, breaks that or news stock can easily reach double digits.
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Nom nom nom bring the gains.
👍️0
$Money Bags$ $Money Bags$ 3 years ago
They are acquiring another company, which pushed the profitability timeline back and it reflected in that. That said, it'll cross the threshold a little harder. Some nice gains whether flipping or bottom feeding long.
👍️0
harr449 harr449 3 years ago
Recent announcement of deal caused PT to go from $14 to $9.
👍️0
$Money Bags$ $Money Bags$ 3 years ago
You guys enjoying the start of this nice run?
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Delicious.
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Once these conversions clear the landscape will probably change quick. I would think we are close too, but...
👍️0
I Dump I Dump 3 years ago
Falcon stocks has them as a buy this week. Holding off yet. Maybe bottom is near.
👍️0
$Money Bags$ $Money Bags$ 3 years ago
So many conversions knocking the floor out of this thing. One day, pow, right in the kisser.
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Conversions on this are still brutal. Float is low, one day she breaks the chains.
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Must be looming conversions. Company events looking good.
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Must be looming conversions. Company events looking good.
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Good news out after hours. $$$
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Wonder if the convertible debt is done now. Looking like it may be. Gonna get interesting when it dries up.
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Made some big buys over the last few days and all of them bared fruit today. Here's to the green mile.
👍️0
mte1955 mte1955 3 years ago
My thoughts exactly. Hopefully the dance continues for this and many other stocks.
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Bought a bunch of 4.38's today. Flip forever and ever here. I still think it'll head north eventually.
👍️0
$Money Bags$ $Money Bags$ 3 years ago
Almost all of the convertible debt is extinguished. At current rate, probably in the next 10 days it will be gone at an average of $3ish a share, hence this hard drop. They have growing revenue, could be building the perfect storm. They have plenty of cash on hand. Started buying at $4.50 and have buys down to $3. Any takes on it?
👍️0
Termite7 Termite7 3 years ago
Good chart!!!
👍️0
trustbutverifyit trustbutverifyit 4 years ago
Amazed this board is so quiet on this ticker. It has been hopping on ST for a month now. $10 coming soon.
👍️0
Cpops Cpops 4 years ago
The secret is out!
👍️0
TFMG TFMG 4 years ago




$XERS | #Xeris Pharma On Breakout Watch



Alert set for a break above the 200ma and $5.00 level.
Highly speculative with high Risk| Reward .
Company profile
Xeris Pharmaceuticals , Inc.is a pharmaceutical company, which develops and commercializes ready-to-use, liquid-stable injectables. It offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL.


PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.






👍️0
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
... GTFOH ... $XERS

EPIC LOSSES
NO CORONA AND LIME
BEER MONEY TRAPPED FOREVER

$XERS went public at 15 only 2 years ago. While 7 looks good to someone buying at 3, there's a lot of investors who'd be taking a loss at 7. The ultra bull case is $XERS gets up to the mid teens organically and then gets a buyout for a big premium in the mid 20s

#ROFLMFAO #EatLOSSES

👍️0
ClayTrader ClayTrader 4 years ago
* * $XERS Video Chart 08-13-2020 * *

Link to Video - click here to watch the technical chart video

👍️0

Your Recent History

NASDAQ
XERS
Xeris Biopharma
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved